1. Diverse innate stimuli activate basophils through pathways involving Syk and IκB kinases.
- Author
-
Pellefigues C, Mehta P, Chappell S, Yumnam B, Old S, Camberis M, and Le Gros G
- Subjects
- Animals, Basophils drug effects, Biomarkers, Cell Degranulation, Cytokines metabolism, Gene Expression, Hormones, Inflammation Mediators metabolism, Mice, Protein Kinase Inhibitors, Basophils immunology, Basophils metabolism, I-kappa B Kinase metabolism, Immunity, Innate drug effects, Signal Transduction drug effects, Syk Kinase metabolism
- Abstract
Mature basophils play critical inflammatory roles during helminthic, autoimmune, and allergic diseases through their secretion of histamine and the type 2 cytokines interleukin 4 (IL-4) and IL-13. Basophils are activated typically by allergen-mediated IgE cross-linking but also by endogenous "innate" factors. The aim of this study was to identify the innate stimuli (cytokines, chemokines, growth factors, hormones, neuropeptides, metabolites, and bacterial products) and signaling pathways inducing primary basophil activation. Basophils from naïve mice or helminth-infected mice were cultured with up to 96 distinct stimuli and their influence on basophil survival, activation, degranulation, and IL-4 or IL-13 expression were investigated. Activated basophils show a heterogeneous phenotype and segregate into distinct subsets expressing IL-4, IL-13, activation, or degranulation markers. We find that several innate stimuli including epithelial derived inflammatory cytokines (IL-33, IL-18, TSLP, and GM-CSF), growth factors (IL-3, IL-7, TGFβ, and VEGF), eicosanoids, metabolites, TLR ligands, and type I IFN exert significant direct effects on basophils. Basophil activation mediated by distinct upstream signaling pathways is always sensitive to Syk and I κ B kinases-specific inhibitors but not necessarily to NFAT, STAT5, adenylate cyclase, or c-fos/AP-1 inhibitors. Thus, basophils are activated by very diverse mediators, but their activation seem controlled by a core checkpoint involving Syk and I κ B kinases., Competing Interests: The authors declare no competing interest.
- Published
- 2021
- Full Text
- View/download PDF